INBRAIN Neuroelectrics is differentiated by its graphene-based implant architecture, which promises thinner, more conformable, and potentially higher-fidelity neural interfaces than conventional materials. Its Series B funding and therapeutic focus in Parkinson’s and epilepsy position it among the more credible next-generation implantable neuroelectronics companies, though it remains pre-commercial.